Genetic therapy for HIV/AIDS. (Q35207524)

7 August 2017

1 reference

title

Genetic therapy for HIV/AIDS. (English)

1 reference

7 August 2017

author name string

Ananthalakshmi Poluri

series ordinal

1

1 reference

7 August 2017

Marc van Maanen

series ordinal

2

1 reference

7 August 2017

Richard E Sutton

series ordinal

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Expert Opinion on Biological Therapy

7 August 2017

published in

1 reference

7 August 2017

volume

3

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

951-963

1 reference

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Intrakines--evidence for a trans-cellular mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Intracellular antibodies (intrabodies) for gene therapy of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Tat trans-activates the human immunodeficiency virus through a nascent RNA target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Cloned zebrafish by nuclear transfer from long-term-cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1 Rev.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Gene therapy of HIV-1 infection using lentiviral vectors expressing anti-HIV-1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Activation of a Diphtheria Toxin A Gene by Expression of Human Immunodeficiency Virus-1 Tat and Rev Proteins in Transfected Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Diphtheria toxin A gene-mediated HIV-1 protection of cord blood-derived T cells in the SCID-hu mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Ablation of tumor cells in vivo by direct injection of HSV-thymidine kinase retroviral vector and ganciclovir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Current developments in the design of onco-retrovirus and lentivirus vector systems for hematopoietic cell gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Gene silencing as a threat to the success of gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Creation of genomic methylation patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Genetic Modification of Human Peripheral Blood Lymphocytes with a Transdominant Negative Form of Rev: Safety and Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.6.951

21 January 2018

Identifiers

DOI

10.1517/14712598.3.6.951

1 reference

7 August 2017

1 reference